VMA21 Rabbit Polyclonal Antibody
Product Images
Other products for "VMA21"
Specifications
| Product Data | |
| Applications | IF, IHC |
| Recommended Dilution | IHC: 150-500 Positive control: Human esophagus cancer Predicted cell location: Cytoplasm |
| Reactivities | Human, Mouse, Rat |
| Host | Rabbit |
| Isotype | IgG |
| Clonality | Polyclonal |
| Immunogen | Synthetic peptide corresponding to a region derived from 3-16 amino acids of human VMA21 vacuolar H+-ATPase homolog (S. cerevisiae) |
| Formulation | PBS pH7.3, 0.05% NaN3, 50% glycerol |
| Concentration | lot specific |
| Purification | Antigen affinity purification |
| Conjugation | Unconjugated |
| Storage | Store at -20°C as received. |
| Stability | Stable for 12 months from date of receipt. |
| Gene Name | VMA21 vacuolar H+-ATPase homolog (S. cerevisiae) |
| Database Link | |
| Background | This gene encodes a chaperone for assembly of lysosomal vacuolar ATPase. Required for the assembly of the V0 complex of the vacuolar ATPase (V-ATPase) in the endoplasmic reticulum. Associates with the V0 complex of the vacuolar ATPase (V-ATPase). MEAX is a childhood-onset disease characterized by progressive vacuolation and atrophy of skeletal muscle. It is inherited in recessive fashion; affecting boys and sparing carrier females. Onset is in childhood; and patients exhibit weakness of the proximal muscles of the lower extremities; progressing slowly to involve other skeletal muscle groups over time. |
| Synonyms | MEAX; XMEA |
| Reference Data | |
| Protein Families | Transmembrane |
Documents
| Product Manuals |
| FAQs |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.
Germany
Japan
United Kingdom
China